Plus Therapeutics (PSTV) Leases (2016 - 2025)
Plus Therapeutics (PSTV) has disclosed Leases for 11 consecutive years, with $1.8 million as the latest value for Q4 2025.
- Quarterly Leases changed 0.0% to $1.8 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $1.8 million through Dec 2025, changed 0.0% year-over-year, with the annual reading at $1.8 million for FY2025, 0.0% changed from the prior year.
- Leases for Q4 2025 was $1.8 million at Plus Therapeutics, up from $20000.0 in the prior quarter.
- The five-year high for Leases was $1.8 million in Q4 2022, with the low at $20000.0 in Q3 2025.
- Average Leases over 5 years is $588315.8, with a median of $275000.0 recorded in 2022.
- The sharpest move saw Leases changed 0.0% in 2023, then plummeted 81.13% in 2025.
- Over 5 years, Leases stood at $559000.0 in 2021, then surged by 223.79% to $1.8 million in 2022, then changed by 0.0% to $1.8 million in 2023, then changed by 0.0% to $1.8 million in 2024, then changed by 0.0% to $1.8 million in 2025.
- According to Business Quant data, Leases over the past three periods came in at $1.8 million, $20000.0, and $29000.0 for Q4 2025, Q3 2025, and Q2 2025 respectively.